Kaivexin 40mg Injection
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Enoxaparin (40mg)
Overview Kaivexin 40mg Injection
Klexon 40mg Injection is an anticoagulant medication preventing and treating dangerous blood clots. It inhibits clot growth and formation. It's also used to prevent venous thromboembolism, including deep vein thrombosis and pulmonary embolism. Administration is subcutaneous, by a healthcare professional; intramuscular injection is contraindicated. Dosage and duration depend on individual factors such as medical history, response to therapy, and the specific condition being addressed, including age and weight. Consistent use is crucial, even without noticeable symptoms, as it prevents future complications; discontinuation may lead to clot formation. Activities increasing bleeding risk should be avoided. Common side effects include injection site discomfort, hemorrhage, headache, thrombocytosis, respiratory difficulties, swelling, anemia, pyrexia, diarrhea, and elevated liver enzymes. Severe headache might indicate intracranial bleeding; intense abdominal pain could suggest gastrointestinal bleeding. Bleeding may be subtle; monitor for symptoms and report concerns promptly. Prior to treatment, disclose conditions such as hypertension, diabetes, or recent cerebrovascular accident. The medication is contraindicated in active bleeding. Inform your physician of all other medications to ensure compatibility. Low body weight may heighten bleeding risk, and alcohol consumption increases the likelihood of gastrointestinal hemorrhage.
Primary Ingredients of Kaivexin 40mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Kaivexin 40mg Injection
Preventing and managing blood clot formation
Major Benefits of Kaivexin 40mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Kaivexin 40mg Injection:
- Bleeding
- Headache
- Low blood platelets
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Fever
- Injection site pain
- Breathing problems
- Edema (swelling)
- Diarrhea
How to use Kaivexin 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kaivexin 40mg Injection works:
Kaivexin 40mg Injection acts as a blood thinner. Its mechanism involves neutralizing specific clotting factors in the blood, thus inhibiting clot development and averting vascular obstructions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kaivexin 40mg Injection may be unsafe; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The administration of Kaivexin 40mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals have indicated minimal or no negative consequences for fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Kaivexin 40mg Injection during breastfeeding is likely safe. Available human data indicates minimal risk to the infant. The drug's transfer into breast milk is low, resulting in negligible quantities reaching the baby, posing no anticipated harm.
DrivingSAFE
Administration of Kaivexin 40mg Injection typically does not impair driving ability.
KidneyCAUTION
For individuals with kidney impairment, administering Kaivexin 40mg Injection requires careful consideration. A modified dosage of Kaivexin 40mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kaivexin 40mg Injection to individuals with hepatic impairment. Physician consultation is recommended. Prudence is advised when prescribing this injection to patients with pre-existing liver conditions.
What if you forget to take Kaivexin 40mg Injection :
Omit a dose of Kaivexin 40mg Injection? Seek your physician's advice.
Facts to Know About Kaivexin 40mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Low-molecular-weight heparin |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Low-molecular-weight heparin (LMWH) |
3,018 People bought this recently